Clarity Pharmaceuticals (ASX:CU6) Marketable Securities : A$14.81 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Clarity Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Clarity Pharmaceuticals's Marketable Securities for the quarter that ended in Dec. 2023 was A$14.81 Mil.

Clarity Pharmaceuticals's annual Marketable Securities increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$37.00 Mil) but then declined from Jun. 2022 (A$37.00 Mil) to Jun. 2023 (A$33.80 Mil).

Clarity Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Clarity Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Marketable Securities Chart

Clarity Pharmaceuticals Annual Data

Trend

Jun22

Jun23

Marketable Securities

37.00

33.80

Clarity Pharmaceuticals Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial			48.50	37.00	18.00	33.80	14.81

Clarity Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Clarity Pharmaceuticals (ASX:CU6) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Clarity Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals (ASX:CU6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

CLRPF:USA

Address

4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015

Website

https://www.claritypharmaceuticals.com

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.

Clarity Pharmaceuticals (ASX:CU6) Headlines

No Headlines